In vitro effects of a chlorhexidine controlled delivery system

Artificial Organs

Volumn 27, Issue 5, 2003, Pages 486-491

  Franco, Carolina Ferreira ^a   Pataro, André Luiz ^a   Ribeiro E Souza, Leandra Cristina ^a   Santos, Vagner Rodrigues ^b   Cortés, María Esperanza ^b   Sinisterra, Rubén Dario ^b  

^a Dentistry School   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chlorhexidine; Controlled release; Cyclodextrin; Substantivity

Indexed keywords

BIOACTIVITY; CONTROLLED DRUG DELIVERY; DISEASE CONTROL; INTEGRATED CIRCUITS; MAMMALS; MICROORGANISMS; SCANNING ELECTRON MICROSCOPY; TARGETED DRUG DELIVERY;

ANTI-MICROBIAL ACTIVITY; BOVINE DENTIN; CHLORHEXIDINE; CONTROLLED RELEASE; CONTROLLED-DELIVERY; IN-VITRO; INCLUSION COMPOUNDS; MORPHOLOGICAL EFFECTS; SUBSTANTIVITY; Β-CD;

CYCLODEXTRINS;

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CHLORHEXIDINE; WATER;

ACTINOBACTERIA; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; CATTLE; CONFERENCE PAPER; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DENTAL CARIES; DENTIN; DESORPTION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; IN VITRO STUDY; KINETICS; NONHUMAN; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROPHYLAXIS; SCANNING ELECTRON MICROSCOPY; STREPTOCOCCUS MUTANS;

ACTINOBACTERIA (CLASS); ANIMALIA; BOS TAURUS; BOVINAE; POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS MUTANS; UNCULTURED ACTINOMYCETE;

EID: 0038065385     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2003.07245.x     Document Type: Conference Paper

References (20)

1. Van Der Ouderaa FJG. Anti-plaque agents. Rationale and prospects for prevention of gingivitis and periodontal disease. J Clin Periodontol 1991;18:447-54.
2. Scheie AA. Modes of action of currently known chemical anti-plaque agents other than chlorhexidine. J Dent Res 1989;68 (Special Issue): 1609-16.
3. Löesche WJ, Syed SA, Schmidt E, Morrison EC. Bacterial profiles of subgingival plaques in periodontitis. J Periodontol 1985;56:447-56.
4. Greenstein G, Polson A. The role of local drug delivery in the management of periodontal diseases: a comprehensive review. J Periodontol 1998;69:507-20.
5. Lang NP, Brecx MC. Chlorhexidine digluconate - an agent for chemical plaque control and prevention of gingival inflammation. J Periodontal Res 1986;Suppl:74-89.
6. Goldstein DL. The local drug delivery of tetracycline, metronidazole and chlorhexidine in periodontal therapy: a literature review. J Dental Hygi 1992;66:410-6.
7. Goodson JM. Pharmacokinetic principles controlling efficacy of oral therapy. J Dent Res 1989;68(Spec. Issue):1625-32.
8. Jeffcoat MK, Bray KS, Ciancio SG. Adjuntive use of a subgingival controlled-release chlorhexidine chip reduces probing depth and improves attachment level compared with scaling and root planning alone. J Periodontol 1998;69:9,989-97.
9. Soskolone WA. New sustained release dosage form of chlorhexidine for dental use. J Periodontal Res 1982;18:330-6.
10. Szejtli J. Cyclodextrin technology, Dordrecht: Kluwer, 1988:1-170.
11. Hedges A. Industrial applications of cyclodextrins. Chem Rev 1998;9:2035-44.
12. Szejtli J, Osa T. Chemistry, physical and biological properties of cyclodextrins. Comprehensive Supramolecular Chemistry, ed. Pergamon. Oxford, v.3 (Cyclodextrins) 1996:5-40.
13. Qi H, Nishihata T, Rytting JH. Study of the interaction between β-cyclodextrin and chlorhexidine. Pharm Res 1994;11:1207.
14. Cortés ME, Sinisterra RD, Avila-Campos MJ, Tortamano N, Rocha RG. Chlorhexidine:β-Cyclodextrin inclusion compound: preparation, characterization and microbiological evaluation. J Inclusion Phenomenon Macrocy Chem 2001;40:297-302.
15. Amaechi BT, Higham SM, Edgar WM. Efficacy of sterilization methods and their effect on enamel demineralization. Caries Res 1998;32(6):441-6.
16. Higuchi T, Connors KA. In Reilly CN, ed. Advances in analytical chemistry and instrumentation, New York: Wiley-Interscience, 1965: v.4, 117-212.
17. Gjermo P, Bonesvol P, Rölla G. Relationship between plaque-inhibiting effect and retention of chlorhexidine in the human oral cavity. Arch Oral Biol 1974;19:1031-4.
18. Soskolne WA, Golomb G, Friedman M, Sela MN. New sustained release dosage form of chlorhexidine for dental use. II. Use in periodontal therapy. J Periodontal Res 1983;18:330-6.
19. Stabholz A, Sela MN, Friedman M, Golomb G, Soskolne WA. Clinical and microbiological effects of sustained release chlorhexidine in periodontal pockets. J Clin Periodontol 1986;783-8.
20. Ernst CP, Prockl K, Willershausen B. The effectiveness and side effects of 0.1% and 0.2% chlorhexidine mouth rinses: a clinical study. Quintessence Int 1998;29:443-8.